Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Deferred Taxes: 2009-2018

Historic Deferred Taxes for China Pharma Holdings (CPHI) over the last 8 years, with Dec 2018 value amounting to -$1,195.

  • China Pharma Holdings' Deferred Taxes fell 103.91% to -$1,195 in Q4 2018 from the same period last year, while for Dec 2018 it was $68,419, marking a year-over-year decrease of 44.21%. This contributed to the annual value of $68,419 for FY2018, which is 44.21% down from last year.
  • Per China Pharma Holdings' latest filing, its Deferred Taxes stood at -$1,195 for Q4 2018, which was down 105.68% from $21,039 recorded in Q3 2018.
  • China Pharma Holdings' 5-year Deferred Taxes high stood at $421,825 for Q3 2015, and its period low was -$1,195 during Q4 2018.
  • Moreover, its 3-year median value for Deferred Taxes was $28,160 (2017), whereas its average is $45,498.
  • Its Deferred Taxes has fluctuated over the past 5 years, first spiked by 2,095.29% in 2015, then crashed by 103.91% in 2018.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Deferred Taxes stood at $19,284 in 2014, then surged by 2,095.29% to $421,825 in 2015, then slumped by 95.07% to $243,131 in 2016, then slumped by 87.45% to $30,525 in 2017, then tumbled by 103.91% to -$1,195 in 2018.
  • Its Deferred Taxes stands at -$1,195 for Q4 2018, versus $21,039 for Q3 2018 and $22,590 for Q2 2018.